Submit To AHA's Emerging Science™ Series!


Protecting Cerebrovascular Function- From Translational 
Science to Clinical Trials

Moderators: Robert O Bonow, Elliott Antman and Robert Harrington


Panelists: Jeffrey Weitz, John M Murkin and Mark Clay



Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial  

Jonathan P Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC  


Discussion Q&A  



Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery

Ronald B Easley, Baylor Coll of Med, Houston, TX


Discussion Q&A 


Questions or Comments?

Abstract Submission
Phone: 217-398-1792
General Information
Posted by Alyson PON Editor on Apr 27, 2012 9:54 AM America/Chicago

Leave a Comment

Log in to post a comment.